Japan announced a road map to tackle the issue of unavailable foreign drugs in the country due to complex approval processes, with plans to develop in-demand medicines by April 2026. The strategy also includes the establishment of over 10 pharmaceutical startups by 2028, aiming to double investment in the sector by that time.
Prime Minister Fumio Kishida emphasized the government’s commitment to advancing drug discovery efforts, ensuring access to essential medicines for both Japanese citizens and the global community. The road map aims to streamline the approval process for foreign drugs, ultimately reducing the phenomenon of “drug loss” in Japan.
This initiative signals Japan’s dedication to innovation in pharmaceuticals, fostering a conducive environment for research and development in the industry. By prioritizing the availability of necessary medications, the government is taking proactive steps to improve healthcare outcomes and meet the needs of patients.
\
[ad_2]
Source link
